SKI Market

A+| A| A-|

Indian Indices

Sensex

76,704.13 633.29
( 0.83%)

Global Indices

Nasdaq

47,030.54 63.12
(0.13%)

Dow Jones

6,739.22 18.84
(0.28%)

Hang Seng

55,100.12 1,399.73
(2.61%)

Nikkei 225

10,289.25 -114.35
(-1.10%)

Forex

USD-INR

92.33 0.01
(0.01%)

EUR-INR

105.92 0.52
(0.49%)

GBP-INR

122.63 0.58
(0.47%)

JPY-INR

0.58 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

52.0221666

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

45.65

368.78

EPS(TTM)

Face Value()

Div & Yield %

1.51

Back

rpsg ventures ltd

Carysil consolidated net profit rises 61.85% in the September 2025 quarter

Nov 10,2025

Net profit of Carysil rose 61.85% to Rs 27.19 crore in the quarter ended September 2025 as against Rs 16.80 crore during the previous quarter ended September 2024. Sales rose 16.23% to Rs 240.67 crore in the quarter ended September 2025 as against Rs 207.07 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	240.67	207.07	16
OPM %	19.16	17.97	-
PBDT	45.88	33.41	37
PBT	36.34	23.57	54
NP	27.19	16.80	62

76,704.13 633.29 ( 0.83%)

47,030.54 63.12 (0.13%)

6,739.22 18.84 (0.28%)

55,100.12 1,399.73 (2.61%)

10,289.25 -114.35 (-1.10%)

92.33 0.01 (0.01%)

105.92 0.52 (0.49%)

122.63 0.58 (0.47%)

0.58 0.00 (0.31%)